Insider Transactions in Q4 2025 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Alexander Hardy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,570
-9.42%
|
$911,350
$55.03 P/Share
|